UPDATE : Tuesday, October 15, 2019
Hanall marks record sales in Q2
Hanall Biopharma said that it registered record-breaking sales and operatin...
by Lee Han-soo  |  2019-07-31 17:00
Novartis fails to expand heart failure drug Entresto’s indication
Novartis said its phase-3 Paragon-HF trial on heart failure treatment Entre...
by Kim Yun-mi  |  2019-07-31 14:26
Hanmi marks ₩270.4 billion in Q2 sales
Hanmi Pharmaceutical said Tuesday that it recorded sales of 270.4 billion w...
by Lee Han-soo  |  2019-07-30 17:26
Kolmar Korea boosts beauty, health biz through acquisitions
Kolmar Korea Holdings, having units in cosmetics, pharmaceuticals, and heal...
by Park Gi-taek  |  2019-07-30 14:43
GC’s Chinese partner applies for Hunter syndrome drug’s sales approval
GC said that CANBridge Pharmaceuticals, its Chinese partner, has applied fo...
by Lee Han-soo  |  2019-07-30 10:49
‘FDA likely to OK 11 blockbuster candidates in August’
The U.S. Food and Drug Administration (FDA) will likely approve 11 innovati...
by Kim Yun-mi  |  2019-07-29 16:55
Top-30 makers produce more than half of drugs
Drug output by 30 largest pharmaceutical companies accounted for 54 percent...
by Lee Hye-seon  |  2019-07-29 16:38
Takeda’s Zejula poised to change local ovarian cancer treatment market
Takeda’s Zejula (ingredient: niraparib) became eligible for an insurance be...
by Kim Yun-mi  |  2019-07-29 12:04
Court extends ‘temporary suspension’ of order to cancel Invossa trials
A local court has decided to temporarily suspend the legal effect of an adm...
by Jeong Sae-im  |  2019-07-26 17:50
SNUBH professor is 1st Asian keynoter at international Alzheimer meet
Professor Kim Sang-yun of Seoul National University Bundang Hospital has be...
by Lee Han-soo  |  2019-07-26 16:08
‘Kolon Life Science to start following up on Invossa-treated patients’
Kolon Life Science will conduct the first test on patients who received Inv...
by Lee Han-soo  |  2019-07-26 12:21
JW Creagene wins US patent for making dendritic cell treatment
JW Creagene said Thursday that it has obtained a patent for its source tech...
by Lee Han-soo  |  2019-07-25 16:39
Merck, Pfizer launch metastatic merkel cell carcinoma treatment in Korea
Merck and Pfizer will address the unmet medical need of patients suffering ...
by Lee Han-soo  |  2019-07-25 15:18
[Focus] Korean biopharmas eye US Humira market
Samsung Bioepis’s Humira biosimilar has secured entry into the U.S. market....
by Jeong Sae-im  |  2019-07-25 15:02
Kolon Life Science ends Invossa deal with Hong Kong partner
Kolon Life Science said it has terminated the supply agreement of Invossa-K...
by Lee Han-soo  |  2019-07-25 11:17
Tecentriq 1st immunotherapy to get coverage regardless of PD-L1 expression
Roche said Tecentriq, its immunotherapy treatment, will receive reimburseme...
by Lee Han-soo  |  2019-07-24 11:59
Alteogen to develop growth hormone for children with Brazilian partner
Alteogen said it has signed a licensing agreement with Cristalia, a Brazili...
by Lee Han-soo  |  2019-07-23 15:57
Hanmi's US partner to expand Poziotinib clinical program
Spectrum Pharmaceuticals, Hanmi Pharmaceutical's U.S. partner, said tha...
by Lee Han-soo  |  2019-07-23 14:25
Merck Biopharma Korea names new general manager
Merck Korea said that it has appointed Javed Alam as the new general manage...
by Lee Han-soo  |  2019-07-23 11:08
‘Doubts about biopharmaceutical-developing ability to change investment pattern’
Korea Investment & Securities said that it expects the investment sentiment...
by By Jeong Sae-im  |  2019-07-23 10:58
Back to Top